Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information
暂无分享,去创建一个
M. Gobbi | N. Colombo | M. Miglino | M. Cea | A. Raiola | A. Kunkl | P. Minetto | F. Guolo | R. Lemoli | G. Fugazza | M. Clavio | C. di Grazia | F. Ballerini | A. Cagnetta | E. Carminati | D. Guardo | Simona Matarese